Certificate of Analysis | ||||
Monoclonal Antibody: | 2B12-IgG4 | |||
Vial: | Yellow Cap; 100µl | |||
Immunogen: | Der p 2 | |||
Isotype: | Human IgG4 | |||
Specificity: | Binds to species specific epitope present on Dermatophagoides pteronyssinus allergen, Der p 2. | |||
Purification: | Produced in vitro by BioVectra dcl bioreactors and purified by chromatography using Protein G. Single heavy and light chain bands on SDS-PAGE. | |||
Concentration: | 1.76 mg/ml in phosphate buffered saline, pH 7.2. Based on A280 for IgG (1.42= 1mg/ml), 0.22μm filtered, preservative free. | |||
Storage: | Store at –20°C | |||
Notes: | Final working dilutions must be determined by end user. | |||
Product Resources: | CH-3 Certificate of Analysis | |||
Related Products: | ||||
For Research Use Only: Not for Diagnostic or Therapeutic Use | ||||
Indoor Biotechnologies 由三家附属公司组成,INDOOR Biotechnologies Inc.(IBI),位于美国弗吉尼亚州夏洛茨维尔,INDOOR Biotechnologies Limited(IBL)位于英国卡迪夫,INDOOR Biotechnologies India(IBIndia),新设立于班加罗尔。Indoor Biotechnologies 遍布全球,在日本,中国和韩国拥有授权分销商,在全球约50个国家/地区销售。 Indoor Biotechnologies 生产纯化的天然和重组过敏原,用于研究和开发过敏诊断和疫苗。该产品系列目前包括 50 种纯化的过敏原,其制造具有高纯度和生物活性。这包括具有低内毒素含量的 LoTox™ 过敏原,专为过敏和哮喘的免疫学研究而设计。